Long-term velaglucerase alfa treatment in children with Gaucher disease type 1 naïve to enzyme replacement therapy or previously treated with imiglucerase

Authors:

Abstract
No abstract available
Funding Information
  • Shire
  • National Institutes of Health (UL1 TR000004)

This publication has 19 references indexed in Scilit: